组合免疫疗法作为克服免疫疗法耐药性的有希望的策略:从出现到下一代方法
Asmita Pandey1,2, Sudhir Kumar Rai2, Li Ma2,3
1Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|February 25, 2026
概括
开发新的组合免疫疗法,整合下一代治疗方法和生物标志物,对于克服癌症治疗中对免疫检查点抑制剂的耐药性至关重要. 这种方法旨在通过针对特定瘤微环境量身定制治疗来个性化治疗并改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 免疫检查点抑制剂 (ICI) 已经在癌症治疗中取得了先进进展,但由于单剂使用和有限的组合成功而面临耐药性.
- 克服耐药性需要新的策略,超越目前的单剂ICI治疗.
研究的目的:
- 审查新兴的组合免疫疗法方法来克服ICI耐药性.
- 强调将下一代免疫疗法和生物标志物的整合用于个性化癌症治疗.
- 讨论从失败的试验和毒性中吸取的经验教训,以指导未来的研究.
主要方法:
- 关于当前和新兴免疫疗法组合的文献综述.
- 对瘤微环境特定的组合策略的分析.
- 评估生物标志物集成以预测和个性化响应.
- 对临床试验设计和适应性策略的审查.
主要成果:
- 根据瘤微环境量身定制的组合方法在克服ICI耐药性方面表现有前途.
- 先进的生物标志物对于预测反应和个性化免疫治疗至关重要.
- 将下一代免疫疗法与ICI整合起来,需要仔细考虑试验设计和毒性.
结论:
- 根据先进的生物标志物和人工智能驱动的平台指导的定制组合免疫疗法是提高癌症治疗疗效的关键.
- 未来的临床试验应纳入适应性,生物标志物引导的设计,以优化组合免疫疗法策略.
- 整合新型免疫疗法和生物标志物的个性化方法对于改善耐药癌症的结果至关重要.
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cytotoxic T Cells-mediated Immune Response
7.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Immunological Memory
17.4K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
17.4K


